» Articles » PMID: 7494273

Identification and Characterization of ZIIBC, a Complex Formed by Cellular Factors and the ZII Site of the Epstein-Barr Virus BZLF1 Promoter

Overview
Journal J Virol
Date 1995 Dec 1
PMID 7494273
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The transition from latency to lytic Epstein-Barr virus replication is dependent on the Epstein-Barr virus BZLF1 gene product. Genetic and biochemical attempts to link cellular second-messenger signaling pathways that trigger this transition with the subsequent viral gene cascade have identified functional elements within the BZLF1 promoter (Zp) that appear to bind undefined cellular transcription factors. One of these previously identified sites, ZII, has homology to consensus AP-1 and CREB binding sites, implying a role for these factors in the inductive process. We have identified and characterized ZIIBC, a ZII site binding complex that is distinct from the factors previously proposed to bind this site. Active ZIIBC was found to be present in both uninduced and chemically induced cell extracts at approximately equivalent concentrations. Analysis of the DNA sequence requirements for the binding of ZIIBC to the ZII site shows that sequences homologous to AP-1 and CREB consensus sites are necessary but not sufficient for complex formation. Although the components of ZIIBC that directly contact DNA were found to be of the same molecular masses (26 and 36 kDa) in both uninduced and chemically induced cell extracts, a slight mobility difference between DNA-protein complexes formed by these two types of extracts is observable and indicates that ZIIBC is directly affected by chemical induction. The effects of ZIIBC binding to the ZII site on expression from Zp were evaluated, and they suggest that ZIIBC plays a critical role in the regulation of Zp expression.

Citing Articles

Ceramide promotes lytic reactivation of Epstein-Barr virus in gastric carcinoma.

Kim J, Min Y, Lee M, An Y, Ashktorab H, Smoot D J Virol. 2024; 98(2):e0177623.

PMID: 38197630 PMC: 10878077. DOI: 10.1128/jvi.01776-23.


ERK/c-Jun Recruits Tet1 to Induce Zta Expression and Epstein-Barr Virus Reactivation through DNA Demethylation.

Zhang W, Han D, Wan P, Pan P, Cao Y, Liu Y Sci Rep. 2016; 6:34543.

PMID: 27708396 PMC: 5052586. DOI: 10.1038/srep34543.


MCAF1 and Rta-activated BZLF1 transcription in Epstein-Barr virus.

Lin T, Chu Y, Yang Y, Hsu S, Liu S, Chang L PLoS One. 2014; 9(3):e90698.

PMID: 24598729 PMC: 3944714. DOI: 10.1371/journal.pone.0090698.


Contribution of myocyte enhancer factor 2 family transcription factors to BZLF1 expression in Epstein-Barr virus reactivation from latency.

Murata T, Narita Y, Sugimoto A, Kawashima D, Kanda T, Tsurumi T J Virol. 2013; 87(18):10148-62.

PMID: 23843637 PMC: 3754021. DOI: 10.1128/JVI.01002-13.


Epigenetic modification of the Epstein-Barr virus BZLF1 promoter regulates viral reactivation from latency.

Murata T, Tsurumi T Front Genet. 2013; 4:53.

PMID: 23577022 PMC: 3620531. DOI: 10.3389/fgene.2013.00053.


References
1.
Miller G . The switch between EBV latency and replication. Yale J Biol Med. 1989; 62(2):205-13. PMC: 2589219. View

2.
Takada K, Ono Y . Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J Virol. 1989; 63(1):445-9. PMC: 247705. DOI: 10.1128/JVI.63.1.445-449.1989. View

3.
Flemington E, Speck S . Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol. 1990; 64(3):1227-32. PMC: 249237. DOI: 10.1128/JVI.64.3.1227-1232.1990. View

4.
Boyle W, Smeal T, Defize L, Angel P, Woodgett J, Karin M . Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell. 1991; 64(3):573-84. DOI: 10.1016/0092-8674(91)90241-p. View

5.
Kouzarides T, Packham G, Cook A, Farrell P . The BZLF1 protein of EBV has a coiled coil dimerisation domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper. Oncogene. 1991; 6(2):195-204. View